DCTPP1 knockdown increases the sensitivity of ovarian cancer cells to cisplatin in cisplatin-sensitive cells, which is reflected in growth inhibition, increased levels of apoptosis and increased DNA damage. This evidence concerns the gene DCTPP1 and ovarian cancer.